Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Immunology and Immunotherapy

We are delighted to share a collection of highly viewed papers on cancer immunology and immunotherapy that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

The list of relevant papers can be seen below:

“KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy”
by Priyanka Uniyal, Vivek Kumar Kashyap, Tapan Behl, Deepak Parashar and Ravi Rawat
Cancers 2025, 17(5), 785; https://doi.org/10.3390/cancers17050785
Available online: https://www.mdpi.com/2072-6694/17/5/785

“Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas”
by Justin W. Miller,Jeffrey S. Johnson,Christopher Guske,Gowtam Mannam, Firas Hatoum,Michelle Nassar,Marine Potez,Adnan Fazili,Philippe E. Spiess and Jad Chahoud
Cancers 2025, 17(2), 326; https://doi.org/10.3390/cancers17020326
Available online: https://www.mdpi.com/2072-6694/17/2/326

“Personalization of Cancer Treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy”
by Rosalyn M. Fey, Avery Billo, Terri Clister, Khanh L. Doan, Elizabeth G. Berry, Deanne C. Tibbitts and Rajan P. Kulkarni
Cancers 2025, 17(5), 732; https://doi.org/10.3390/cancers17050732
Available online: https://www.mdpi.com/2072-6694/17/5/732

“Advancing Immunotherapy in Pancreatic Cancer: A Brief Review of Emerging Adoptive Cell Therapies”
by Deepak Sherpally and Ashish Manne
Cancers 2025, 17(4), 589; https://doi.org/10.3390/cancers17040589
Available online: https://www.mdpi.com/2072-6694/17/4/589

“Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy”
by Michael S. Oh, Jensen Abascal, Austin K. Rennels, Ramin Salehi-Rad, Steven M. Dubinett and Bin Liu
Cancers 2025, 17(6), 1027; https://doi.org/10.3390/cancers17061027
Available online: https://www.mdpi.com/2072-6694/17/6/1027

“Personalized Immunity: Neoantigen-Based Vaccines Revolutionizing Hepatocellular Carcinoma Treatment”
by Ioanna Aggeletopoulou, Spyridon Pantzios and Christos Triantos
Cancers 2025, 17(3), 376; https://doi.org/10.3390/cancers17030376
Available online: https://www.mdpi.com/2072-6694/17/3/376

Special Issues:
“CAR T Cells in Lymphoma and Multiple Myeloma”
Guest Editors: Dr. Javier Munoz and Dr. Julia Erin Wiedmeier-Nutor
Submission deadline: 31 January 2026

“Immune Microenvironment and Immunotherapy in Malignant Brain Tumors”
Guest Editors: Dr. Masaki Terabe and Prof. Dr. Mark R. Gilbert
Submission deadline: 30 April 2026

“Cancer Immunotherapy: Focus on Immune Checkpoint Inhibitors and Immune Modulators”
Guest Editor: Dr. Katsuaki Ieguchi
Submission deadline: 30 March 2026

“Immunotherapy for Skin Cancers”
Guest Editors: Prof. Dr. Reinhard Dummer and Dr. Lara Valeska Maul-Duwendag
Submission deadline: 10 March 2026

You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office